<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">For evidence-based healthcare, systematic reviews and meta-analyses comprehensively summarize data from multiple resources, and are positioned at the top of the evidence hierarchy [
 <xref rid="bb0040" ref-type="bibr">8</xref>]. However, traditional systematic reviews and meta-analyses only retrospectively include published studies. Given that positive results are more likely to be published, this process then bears the high risk of selection and publication biases. With respect to COVID-19, most of the registered trials are still ongoing and few have been published [
 <xref rid="bb0005" ref-type="bibr">1</xref>]. Even after completion of these trials, there will be time lags for the peer-review and publication processes, even though preprint servers have greatly facilitated the speed at which COVID-19 research data are being shared.
</p>
